Free Trial

NAYA Biosciences (NAYA) Competitors

NAYA Biosciences logo
$0.86 -0.01 (-1.31%)
As of 07/3/2025

NAYA vs. NDRA, LGMK, BJDX, BBLG, NAOV, IVF, AVGR, NUWE, DYNT, and CUTR

Should you be buying NAYA Biosciences stock or one of its competitors? The main competitors of NAYA Biosciences include ENDRA Life Sciences (NDRA), LogicMark (LGMK), Bluejay Diagnostics (BJDX), Bone Biologics (BBLG), Nanovibronix (NAOV), INVO Fertility (IVF), Avinger (AVGR), Nuwellis (NUWE), Dynatronics (DYNT), and Cutera (CUTR). These companies are all part of the "medical equipment" industry.

NAYA Biosciences vs. Its Competitors

NAYA Biosciences (NASDAQ:NAYA) and ENDRA Life Sciences (NASDAQ:NDRA) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, valuation, risk, media sentiment and analyst recommendations.

ENDRA Life Sciences has a net margin of 0.00% compared to NAYA Biosciences' net margin of -119.91%. NAYA Biosciences' return on equity of 0.00% beat ENDRA Life Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
NAYA Biosciences-119.91% N/A -41.72%
ENDRA Life Sciences N/A -140.96%-106.14%

NAYA Biosciences presently has a consensus price target of $24.00, suggesting a potential upside of 2,677.78%. ENDRA Life Sciences has a consensus price target of $50.00, suggesting a potential upside of 1,347.18%. Given NAYA Biosciences' higher possible upside, equities research analysts plainly believe NAYA Biosciences is more favorable than ENDRA Life Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NAYA Biosciences
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
ENDRA Life Sciences
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, ENDRA Life Sciences had 1 more articles in the media than NAYA Biosciences. MarketBeat recorded 1 mentions for ENDRA Life Sciences and 0 mentions for NAYA Biosciences. NAYA Biosciences' average media sentiment score of 0.00 equaled ENDRA Life Sciences'average media sentiment score.

Company Overall Sentiment
NAYA Biosciences Neutral
ENDRA Life Sciences Neutral

12.0% of NAYA Biosciences shares are held by institutional investors. Comparatively, 1.2% of ENDRA Life Sciences shares are held by institutional investors. 1.8% of NAYA Biosciences shares are held by insiders. Comparatively, 0.0% of ENDRA Life Sciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

NAYA Biosciences has higher revenue and earnings than ENDRA Life Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NAYA Biosciences$6.23M0.09-$8.03MN/AN/A
ENDRA Life SciencesN/AN/A-$11.51M-$172.04-0.02

NAYA Biosciences has a beta of 2.03, indicating that its share price is 103% more volatile than the S&P 500. Comparatively, ENDRA Life Sciences has a beta of -0.18, indicating that its share price is 118% less volatile than the S&P 500.

Summary

NAYA Biosciences beats ENDRA Life Sciences on 8 of the 10 factors compared between the two stocks.

Get NAYA Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for NAYA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NAYA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NAYA vs. The Competition

MetricNAYA BiosciencesSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$575K$256.84M$5.50B$9.02B
Dividend YieldN/AN/A5.38%4.10%
P/E RatioN/A5.9227.6020.30
Price / Sales0.0973.84369.54104.24
Price / CashN/A196.1236.6357.47
Price / Book-0.426.128.055.68
Net Income-$8.03M-$27.18M$3.18B$249.13M
7 Day Performance-16.92%-1.02%2.82%3.30%
1 Month Performance-46.67%-7.04%3.69%5.20%
1 Year PerformanceN/A25.77%35.41%21.37%

NAYA Biosciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NAYA
NAYA Biosciences
N/A$0.86
-1.3%
$24.00
+2,677.8%
N/A$575K$6.23M0.0010
NDRA
ENDRA Life Sciences
2.6165 of 5 stars
$3.51
+1.4%
$50.00
+1,324.5%
-100.0%$2.55MN/A-0.0220News Coverage
LGMK
LogicMark
0.3146 of 5 stars
$0.00
+2.5%
N/A-100.0%$2.36M$9.88M0.0020Gap Down
BJDX
Bluejay Diagnostics
0.1072 of 5 stars
$1.56
-1.3%
N/A-94.7%$2.36M$250K0.009
BBLG
Bone Biologics
1.1218 of 5 stars
$4.16
-0.7%
N/A-51.7%$2.28MN/A0.002
NAOV
Nanovibronix
0.2883 of 5 stars
$0.87
-1.1%
N/A-88.1%$2.27M$2.56M-0.0620High Trading Volume
IVF
INVO Fertility
N/A$1.04
+2.0%
N/AN/A$2.20M$6.53M-0.0310
AVGR
Avinger
N/A$0.47
flat
N/AN/A$1.57M$7.65M-0.0470
NUWE
Nuwellis
1.8658 of 5 stars
$0.26
+1.1%
$17.00
+6,489.1%
-95.2%$1.12M$8.74M-0.0170News Coverage
Gap Down
DYNT
Dynatronics
0.3154 of 5 stars
$0.08
+9.3%
N/A-67.6%$812K$33.60M-0.09200News Coverage
Gap Down
CUTR
Cutera
N/A$0.04
-63.9%
$3.00
+7,592.3%
-97.0%$787K$155.21M-0.01460Gap Down
High Trading Volume

Related Companies and Tools


This page (NASDAQ:NAYA) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners